GM-CSF/Ipilimumab Combination Extends Melanoma Survival

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2013-083
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Gm-CSF

2018English

Commanding CNS Invasion: GM-CSF

Immunity
Infectious DiseasesAllergyImmunology
2017English

Anti‐GM‐CSF Therapy in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Paraneoplastic Hyperleucocytosis in a Melanoma Patient After Initiation of Ipilimumab and Nivolumab Combination Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Novel GM-CSF-based Vaccines: One Small Step in GM-CSF Gene Optimization, One Giant Leap for Human Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

GM-CSF Administration Improves Defects in Innate Immunity and Sepsis Survival in Obese Diabetic Mice

Journal of Immunology
AllergyImmunology
2018English

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated With Ipilimumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

GM-CSF Therapy in Pulmonary Alveolar Proteinosis

Thorax
PulmonaryRespiratory Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy